All Substitutes

Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
PALBACE 125MG CAPSULE_1
PALBACE 125MG CAPSULE_2
PALBACE 125MG CAPSULE_1
20% Off

Palbace 125mg Capsule

Prescription Required

Salt Composition : Palbociclib

Manufacturer : PFIZER LTD

Origin of Medicine : United States of America

MRP: ₹95000
Price : ₹75750
You Save : ₹19250 (20%)

21 Capsule(s) In A Box

PAP Information :    Buy 1, get 3 Free. Contact us for latest updates.

Patient Assistance Programs
Know About PAP

Program Overview: PFIZER LTD's Patient Assistance Program (PAP) is dedicated to helping patients in need of PALBACE 125MG CAPSULE. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 1 box of Palbace 125mg capsules, and you will receive 3 free additional boxes. Therefore, if eligible, you will have to pay only Rs. 75,750 for four boxes, which is Rs. 18,938 per box. 

With MrMed's MRP discount of Rs. 19,250 per box and Pfizer’s PAP program, the overall savings is over Rs. 3 lakhs per purchase. 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the Palbace Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Palbociclib 125mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Pfizer can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: PFIZER LTD's Patient Assistance Program (PAP) is dedicated to helping patients in need of PALBACE 125MG CAPSULE. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 1 box of Palbace 125mg capsules, and you will receive 3 free additional boxes. Therefore, if eligible, you will have to pay only Rs. 75,750 for four boxes, which is Rs. 18,938 per box. 

With MrMed's MRP discount of Rs. 19,250 per box and Pfizer’s PAP program, the overall savings is over Rs. 3 lakhs per purchase. 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the Palbace Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Palbociclib 125mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Pfizer can avail of it without having to purchase the medication from MrMed.

Introduction to Palbace 125mg Capsule

Palbace 125 mg is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications. 

The common side effects that are likely to associate with Palbace 125 mg are nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persists in you.  

Inform your healthcare provider if you are allergic to Palbace 125 mg and its ingredients. Before taking this medicine, it is vital to inform your doctor if you have any signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to some sugars. Consult your physician immediately if you experience symptoms such as dry cough, chest pain, or difficulty breathing, as it could indicate lung inflammation. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication. Use effective birth control during the treatment and at least three weeks after the last dose. It is not recommended for adolescents and children under 18 years of age. 

Uses of Palbace 125mg Capsule

  • Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.

Therapeutic Effects of Palbace 125mg Capsule

Palbace 125 mg works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.  

Interaction of Palbace 125mg Capsule with other drugs

Inform your doctor about all medications including prescribed, over-the-counter, nutritional or vitamin supplements and herbal products that you are taking or have taken before the treatment. Concurrent use of palbociclib with CYP3A4 inhibitors such as fentanyl has reported increased fentanyl toxicity. certain medications may interact with the effectiveness of this drug. 

More Information about Palbace 125mg Capsule

  • Keep Palbace 125 mg out of sight and reach of children.
  • Store at 20°C to 25°C.

How to consume Palbace 125mg Capsule

Take Palbace 125 mg exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule. 

Safety Advices for Palbace 125mg Capsule

Image Not Available  

Pregnancy

  

It is not recommended to take Palbace 125 mg during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment. 

Image Not Available  

Breast Feeding

  

It is not recommended to take Palbace 125 mg while breastfeeding as it is not known whether it passes into the breast milk.   

Image Not Available  

Lungs

  

It is not unknown whether palbace 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Image Not Available  

Liver

  

Inform your physician if you have any liver disorders before taking Palbace 125 mg, as it should be used with caution in liver disorder patients. 

Image Not Available  

Alcohol

  

It is unknown whether it is safe to drink alcohol while taking Palbace 125 mg. Check with your doctor for advice.  

Image Not Available  

Driving

  

Palbace 125 mg can cause tiredness. Avoid driving if you are unwell

Side Effects of Palbace 125mg Capsule

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. 

Serious:

  • Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
  • Lung inflammation (chest pain, dry cough, or difficulty breathing)

Common:

  • Tiredness
  • Hair loss
  • Dry skin, rash
  • Infections
  • Low blood cell counts
  • Decreased of appetite
  • Nausea, vomiting
  • Diarrhea
  • Swelling of lips and mouth
  • Changes in taste
  • Nose bleed
  • Dry eye, blurred vision, increased tearing

Word of Advice

During Palbace 125 mg treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment as well as for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether Palbace 125 mg affects your blood cells.

FAQs

Q 1. Is Palbace 125 mg targeted therapy?

Yes, Palbace 125 mg is a targeted therapy. This medication belongs to the class of cyclin-dependent kinase inhibitors.

Q 2. Do you lose hair on Palbace 125 mg?

Yes, Taking Palbace 125 mg can cause hair loss or hair thinning. It is one of the side effects of this medication. Consult your doctor if any side effects disturb you.

Q 3. Can children use Palbace 125 mg?

No, Palbace 125 mg is not recommended for adolescents and children under 18.

Q 4. Does Palbace 125 mg affect fertility?

Yes, Palbace 125 mg may reduce fertility in men. It may affect your ability to become a father and a child. Hence, men should consider sperm preservation before taking this medication.

Q 5. Does Palbace 125 mg affect blood cell count?

Palbace 125 mg might reduce the number of white blood cells and weaken the immune system. It could lead to an increase in the risk of infections. Regular blood tests while taking Palbace 125 mg are advised.

Fact Box of Palbace 125mg Capsule

Molecule name: Palbociclib

Therapeutic class: Cyclin-dependent kinase inhibitor

Pharmacological class: Anti-Neoplastics

Indications: HR-positive, HER2-negative advanced or metastatic breast cancer 

References

  1. Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
  2. Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
  3. Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
  4. Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.